Inquire About a Product| Product: | Gabapentin-d4 hydrochloride | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D3436 | ||||||||
| CAS Number: | 1432061-73-8 | ||||||||
| Synonyms: | Neurontin-d4 | ||||||||
| Pricing: |
|
||||||||
| Formula: | C9H13D4NO2 . HCl | ||||||||
| Enrichment: | >98% | ||||||||
| Molecular Weight: | 175.26 | ||||||||
| Structure: |
|
||||||||
| Appearance: | White solid | ||||||||
| Category: | Labeled Reference Standards | ||||||||
| Stability: | Stable under recommended storage conditions. | ||||||||
| Storage: |
Store at room temperature; adequate ventilation. |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
Goa, KL; Sorkin, EM, Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs, 1993, Sept., 46 (3): 409–27.; Dauri, M; Faria, S; Gatti, A; Celidonio, L; Carpenedo, R; Sabato, AF, Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences. Current drug targets, 2009, Aug. 10 (8): 716–33.; Bar Ad, V., Gabapentin for the treatment of cancer-related pain syndromes. Reviews on Recent Clinical Trials, 2010, Sept., 5 (3): 174–8. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled anticonvulsant and analgesic. Used to treat seizures, neuropathic pain, and restless leg syndrome. Inhibits the neurotransmitter gamma-Aminobutyric Acid. Gabapentin is structurally related to gamma-Aminobutyric Acid (GABA) and designed to cross the blood brain barrier. |